DelveInsight’s Hereditary angioedema (HAE) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Hereditary angioedema (HAE) for the seven major markets i.e. United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Hereditary angioedema (HAE) forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Hereditary angioedema (HAE) till 2023.
Key Coverage and Benefits
• The report will help in developing business strategies by understanding the trends shaping and driving the global Hereditary angioedema (HAE) market.
• Identifying patient populations in the global “Hereditary angioedema (HAE) market to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the best opportunities for Hereditary angioedema (HAE) therapeutics in each of the markets covered.
• To understand the future market competition in the global Hereditary angioedema (HAE) therapeutics market and Insightful review of the key market drivers and barriers.
Scope
• Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
• Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2023.
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.
• It also provides Hereditary angioedema (HAE) for United States, EU5 and Japan from 2013 and forecasted Market to 2023.
Note: This report requires 7-10 business days to complete.
'
Table of Contents
• Hereditary angioedema (HAE) overview
• Pathophysiology
• Symptoms of disease
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global Hereditary angioedema (HAE) Market
• Global Epidemiology of Hereditary angioedema (HAE) Forecasted to 2023
• Global Market (2013-2015)
• Global Forecasted Market (2016-2023)
• Global Market by Geography
• Market of US (2013-2015)
• Forecasted Market of US (2016-2023)
• Market of Europe
• Market of Germany (2013-2015)
• Forecasted Market of Germany (2016-2023)
• Market of United Kingdom (2013-2015)
• Forecasted Market of United Kingdom (2016-2023)
• Market of France (2013-2015)
• Forecasted Market of France (2016-2023)
• Market of Italy (2013-2015)
• Forecasted Market of Italy (2016-2023)
• Market of Spain (2013-2015)
• Forecasted Market of Spain (2016-2023)
• Market of Japan (2013-2015)
• Forecasted Market of Japan (2016-2023)
• Market of ROW (2013-2015)
• Forecasted Market of ROW (2016-2023)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight
List of Tables
• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: Hereditary angioedema (HAE) Drug Sales (USD Millions)
• Table 6: Global Epidemiology of Hereditary angioedema (HAE) (2013-2023)
• Table 7: Hereditary angioedema (HAE) Global Market (USD Millions), (2013-2015)
• Table 8: Hereditary angioedema (HAE) Global Market (USD Millions), (2016-2023)
• Table 9: Hereditary angioedema (HAE) US Market (USD Millions), (2013-2015)
• Table 10: Hereditary angioedema (HAE) US Market (USD Millions), (2016-2023)
• Table 11: Hereditary angioedema (HAE) Germany Market (USD Millions), (2013-2015)
• Table 12: Hereditary angioedema (HAE) Germany Market (USD Millions), (2016-2023)
• Table 13: Hereditary angioedema (HAE) United Kingdom Market (USD Millions), (2013-2015)
• Table 14: Hereditary angioedema (HAE) United Kingdom Market (USD Millions), (2016-2023)
• Table 15: Hereditary angioedema (HAE) France Market (USD Millions), (2013-2015)
• Table 16: Hereditary angioedema (HAE) France Market (USD Millions), (2016-2023)
• Table 17: Hereditary angioedema (HAE) Italy Market (USD Millions), (2013-2015)
• Table 18: Hereditary angioedema (HAE) Italy Market (USD Millions), (2016-2023)
• Table 19: Hereditary angioedema (HAE) Spain Market (USD Millions), (2013-2015)
• Table 20: Hereditary angioedema (HAE) Spain Market (USD Millions), (2016-2023)
• Table 21: Hereditary angioedema (HAE) Japan Market (USD Millions), (2013-2015)
• Table 22: Hereditary angioedema (HAE) Japan Market (USD Millions), (2016-2023)
• Table 23: Hereditary angioedema (HAE) ROW Market (USD Millions), (2013-2015)
• Table 24: Hereditary angioedema (HAE) ROW Market (USD Millions), (2016-2023)
List of Figures
• Figure 1: Hereditary angioedema (HAE) Drug Sales (USD Millions)
• Figure 2: Global Epidemiology of Hereditary angioedema (HAE) (2013-2023)
• Figure 3: Hereditary angioedema (HAE) Global Market (USD Millions), (2013-2015)
• Figure 4: Hereditary angioedema (HAE) Global Market (USD Millions), (2016-2023)
• Figure 5: Hereditary angioedema (HAE) US Market (USD Millions), (2013-2015)
• Figure 6: Hereditary angioedema (HAE) US Market (USD Millions), (2016-2023)
• Figure 7: Hereditary angioedema (HAE) Germany Market (USD Millions), (2013-2015)
• Figure 8: Hereditary angioedema (HAE) Germany Market (USD Millions), (2016-2023)
• Figure 9: Hereditary angioedema (HAE) United Kingdom Market (USD Millions), (2013-2015)
• Figure 10: Hereditary angioedema (HAE) United Kingdom Market (USD Millions), (2016-2023)
• Figure 11: Hereditary angioedema (HAE) France Market (USD Millions), (2013-2015)
• Figure 12: Hereditary angioedema (HAE) France Market (USD Millions), (2016-2023)
• Figure 13: Hereditary angioedema (HAE) Italy Market (USD Millions), (2013-2015)
• Figure 14: Hereditary angioedema (HAE) Italy Market (USD Millions), (2016-2023)
• Figure 15: Hereditary angioedema (HAE) Spain Market (USD Millions), (2013-2015)
• Figure 16: Hereditary angioedema (HAE) Spain Market (USD Millions), (2016-2023)
• Figure 17: Hereditary angioedema (HAE) Japan Market (USD Millions), (2013-2015)
• Figure 18: Hereditary angioedema (HAE) Japan Market (USD Millions), (2015-2023)
• Figure 19: Hereditary angioedema (HAE) ROW Market (USD Millions), (2013-2015)
• Figure 20: Hereditary angioedema (HAE) ROW Market (USD Millions), (2016-2023)
• BioCryst Pharmaceuticals Inc.
• Cevec Pharmaceuticals GmbH
• CSL Limited
• Dyax Corp.
• Global Blood Therapeutics Inc.
• iBio Inc.
• Isis Pharmaceuticals Inc.
• Pharming Group N.V.
• Ra Pharmaceuticals Inc.
• Shire Plc
